Veeva to Release Fiscal 2020 First Quarter Results on May 29, 2019
PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE:VEEV) will announce financial results for its fiscal first quarter which ended April 30, 2019 after…
Pharmaceuticals, Biotechnology and Life Sciences
PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE:VEEV) will announce financial results for its fiscal first quarter which ended April 30, 2019 after…
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company (to be…
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…
–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CARTCR?src=hash" target="_blank"gt;#CARTCRlt;/agt;–Nuvera Life Science Consulting is a consulting company dedicated to helping the world’s leading pharmaceutical and biotech…
HONG KONG–(BUSINESS WIRE)–TAKE2 HEALTH LTD. (“TAKE2”), a healthcare technology company based in Hong Kong, China, today announced that it has…
ROSEMONT, Ill.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CSO?src=hash" target="_blank"gt;#CSOlt;/agt;–Proteintech, the benchmark in antibodies and proteins, welcomes Deepa Shankar, PhD, as the head of global…
– Presentations at AUA2019 explore Axumin detection rate and relationship to PSA levels, based on extent of recurrence and prior…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for…